These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37010718)

  • 1. Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8/NF-κB/micro RNA-31, AKT/mTOR/P70S6K milieu, and Tregs/Th17 balance.
    Shahine Y; El-Aal SAA; Reda AM; Sheta E; Atia NM; Abdallah OY; Ibrahim SSA
    Inflammopharmacology; 2023 Jun; 31(3):1341-1359. PubMed ID: 37010718
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice.
    Li Y; Zhang G; Chen M; Tong M; Zhao M; Tang F; Xiao R; Wen H
    Biomed Pharmacother; 2019 Jan; 109():1876-1883. PubMed ID: 30551443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Bcl-3 alleviates psoriasis and dyslipidemia comorbidity by regulating Akt pathway.
    Li W; Yang W; Yang C
    Allergol Immunopathol (Madr); 2022; 50(6):115-121. PubMed ID: 36335454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
    Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
    Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways.
    Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R
    Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
    Roy T; Banang-Mbeumi S; Boateng ST; Ruiz EM; Chamcheu RN; Kang L; King JA; Walker AL; Nagalo BM; Kousoulas KG; Esnault S; Huang S; Chamcheu JC
    Front Immunol; 2022; 13():1075804. PubMed ID: 36741386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
    Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
    Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
    Shi Q; He Q; Chen W; Long J; Zhang B
    J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide attenuates IMQ-induced inflammation in a mouse model of psoriasis.
    Jia HY; Qiu HY; Zhang MD; Hou JJ; Zhou ML; Wu Y
    Biomed Pharmacother; 2022 Dec; 156():113883. PubMed ID: 36270258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-κB/MAPK/Nrf2 pathways.
    Xiong Y; Wang J; Wang S; Li H; Zhou X
    J Nat Med; 2023 Jan; 77(1):188-201. PubMed ID: 36378401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
    Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice.
    Salman HR; Al-Zubaidy AA; Abbas AH; Zigam QA
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):599-616. PubMed ID: 37490123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.
    Irrera N; Bitto A; Vaccaro M; Mannino F; Squadrito V; Pallio G; Arcoraci V; Minutoli L; Ieni A; Lentini M; Altavilla D; Squadrito F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
    Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH
    Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
    Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway.
    Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J
    Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.